Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index; 21 of the 83 sources its claims cite were checked for support.
Abstract
Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in individuals with obesity due to metabolic changes associated with a sedentary lifestyle, adipose tissue derangements, comorbidities (acute and chronic diseases) and during the ageing process. Co-existence of excess adiposity and low muscle mass/function is referred to as sarcopenic obesity (SO), a condition increasingly recognized for its clinical and functional features that negatively influence important patient-centred outcomes. Effective prevention and treatment strategies for SO are urgently needed, but efforts are hampered by the lack of a universally established SO definition and diagnostic criteria. Resulting inconsistencies in the literature also negatively affect the ability to define prevalence as well as clinical relevance of SO for negative health outcomes. Aims and Methods: The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) launched an initiative to reach expert consensus on a definition and diagnostic criteria for SO. The jointly appointed international expert panel proposes that SO is defined as the co-existence of excess adiposity and low muscle mass/function. The diagnosis of SO should be considered in at-risk individuals who screen positive for a co-occurring elevated body mass index or waist circumference, and markers of low skeletal muscle mass and function (risk factors, clinical symptoms, or validated questionnaires). Diagnostic procedures should initially include assessment of skeletal muscle function, followed by assessment of body composition where presence of excess adiposity and low skeletal muscle mass or related body compartments confirm the diagnosis of SO. Individuals with SO should be further stratified into stage I in the absence of clinical complications or stage II if cases are associated with complications linked to altered body composition or skeletal muscle dysfunction. Conclusions: ESPEN and EASO, as well as the expert international panel, advocate that the proposed SO definition and diagnostic criteria be implemented into routine clinical practice. The panel also encourages prospective studies in addition to secondary analysis of existing data sets, to study the predictive value, treatment efficacy and clinical impact of this SO definition.
Overview
CoChat Summary
TL;DR
This ESPEN/EASO consensus statement defines sarcopenic obesity (SO) as the co-existence of excess adiposity and low muscle mass/function and proposes a screening, diagnosis, and staging algorithm. After a four-phase Delphi process, the expert panel reached 93.6% agreement on the global proposal.
Key findings
- SO is defined as the co-existence of obesity and sarcopenia: obesity as high body fat percentage, and sarcopenia as low skeletal muscle mass accompanied by low muscle function. Diagnosis requires both altered skeletal muscle functional parameters and altered body composition after positive screening.
- Screening uses elevated BMI or waist circumference with ethnicity-specific cut points plus surrogate indicators/risk factors or validated questionnaires (e.g., SARC-F in older subjects); all people with obesity/overweight above age 70 are considered at risk of SO.
- Diagnostic sequence: assess skeletal muscle function first (e.g., hand-grip strength, knee extensor strength, chair-stand test), then body composition by DXA or BIA as second choice, with CT when possible. The panel suggests cut points from Dodds et al. and Chen et al. for HGS, Gallagher et al. for FM, Janssen et al. for SMM/W, and Batsis et al. for ALM/W. Staging is Stage I (no complications) or Stage II (at least one complication attributable to altered body composition and skeletal muscle functional parameters).
- The background systematic review found unified fat-plus-muscle parameters in only 6 of 75 selected studies; 28 of 75 studies had a mean age below 65 years. In a sample of 727 participants with obesity, SO prevalence was 34.8% in males and 50.1% in females; in another sample of 147 individuals with obesity, 63.3% met criteria for reduced lean mass. Proposed upper sex-specific body fat cut-offs were 40% for females and 30% for males.
Methods
- ESPEN and EASO launched a consensus initiative following standard operating procedures for ESPEN guidelines and consensus papers. A pool of 38 international researchers from 16 countries on four continents contributed, with five members coordinating.
- The consensus procedure used a four-phase Delphi process with sequential web-based questionnaires (rounds in 2020–2021). Participants ranked statements on a 5-point Likert scale, and statements with >75% positive responses (agree or strongly agree) advanced.
- After four rounds, the global proposal encompassing SO definition, screening, diagnosis, and staging reached 93.6% agreement (agree + strongly agree).
Limitations
- Stated: the statements are expert-based rather than necessarily evidence-based; the group was self-appointed, initiated by ESPEN and EASO representatives with subsequent expert panel selection. Lack of consistency in prior operational criteria may affect any consensus initiative.
- Stated: the staging proposal has not been investigated and is based entirely on clinical expert opinion. No universally accepted validated references are available for most parameters; it remains unclear whether T scores or Z scores should be used, and cut-offs need validation against specific adverse outcomes.
- Evident from the text: the proposed algorithm and staging are not empirically tested in this paper, and many cited cut-offs come from heterogeneous populations by age, sex, and ethnicity, with most studies in Caucasian groups, limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 3 Not valid · 34 Not checked · 37 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, near-normal skeletal muscle mass according to reference ranges for the general non-obese population may be accompanied by lower or inadequate muscle strength and performance in individuals with obesity [82].”
What the sources say
- Partly supportedcites [82] matched to “Muscle ectopic fat deposition contributes to anabolic resistance in obese sarcopenic old rats through e IF 2α activation” (2014) sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports that muscle fat accumulation in older people is associated with reduced strength and poorer performance-test scores. It does not establish that people with obesity can have near-normal muscle mass by non-obese reference ranges while having inadequate strength or performance; the paper’s own experiments concern old rats. (LLM, conf=0.82)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Individuals with obesity may conversely have comparable or even higher absolute skeletal muscle mass relative to nonobese counterparts, due to higher overall body mass and potentially higher related muscle workload in daily physical activity [80, 81].”
What the sources say
- Could not verifycites [80] matched to “Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention” (2014) sourceExperimental — accuracy not yet measured
The section “The Value of Assessing LST: Clinical Considerations” discusses muscle loss occurring alongside obesity, but does not compare absolute skeletal muscle mass in obese and nonobese people. Searches for that comparison and for increased muscle workload from higher body mass found no passage addressing either point. (LLM, conf=0.73)
- Partly supportedcites [81] matched to “Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging” (2020) sourceExperimental — accuracy not yet measured
The Calorie Restriction section (page unavailable) reports that obese adults had larger muscle-fiber cross-sectional area, which lends limited support to the comparison with nonobese adults. It does not establish that they have comparable or higher absolute skeletal muscle mass, or attribute any difference to body mass or greater muscle workload during daily activity. (LLM, conf=0.78)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In 28 of the 75 studies selected in our recent SO systematic review [20], the mean age of the studied population was below 65 years.”
What the sources say
- Partly supportedcites [20] matched to “Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review” (2020) sourceExperimental — accuracy not yet measured
The 'Study characteristics' section (p. 1 of our copy) confirms the denominator and the age theme: 75 articles were selected and 'the mean age of the participants was 64.8±4.5 years (range: 20-92)', and 'Search results' confirms the 75 included studies. However, nowhere in our copy is the specific count '28 studies with a mean age below 65 years' stated; Table 1 lists per-study ages (e.g. An KO 58.7, Baek J 43.55, Kim YS 31.0/30.8, Srikanthan 45.0) from which such a figure could be derived, but the paper itself reports only the pooled mean age, not a tally of studies above/below 65. So the 75-study part is supported and the '28' figure is not attributable to this source as printed. (LLM, conf=0.68)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Moreover, the unified parameters differed in the respective studies [20].”
What the sources say
- Supportedcites [20] matched to “Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review” (2020) source
The DISCUSSION section states that 'only a minority of studies selected in the present systematic review have employed unified parameters with both fat and muscle measurements related in a single criterion', and then lists the differing examples used by different studies (visceral FM/ASMI ratio in Siervo et al., visceral adipose tissue/thigh muscle ratios from CT in K-NHANES and East Asian cohorts). The 'Definitions of sarcopenic obesity' section corroborates this heterogeneity: 3 studies used residuals of linear regression predicting AFFM, while 2 studies used FM/FFM or visceral adipose tissue area to thigh muscle area ratios [41,70]. Together these passages support that the unified parameters differed across the reviewed studies. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“while recognizing the important limitations of BMI in the detection of fat distribution and body composition [24, 25, 93].”
What the sources say
- Supportedcites [24] matched to “Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999–2004” (2016) source
The Discussion (page not provided) states that BMI suboptimally identifies adiposity when compared with DEXA body-composition measures. It also notes differences associated with central obesity in people misclassified by BMI, supporting the stated limitation concerning fat distribution. (LLM, conf=0.90)
- Partly supportedcites [25] matched to “New Criteria for `Obesity Disease' in Japan” (2002) sourceExperimental — accuracy not yet measured
In “Assessing Visceral Fat Accumulation by CT Scanning” (page unavailable), BMI correlated weakly with visceral fat area, supporting a limitation in detecting fat distribution. The paper does not separately establish the claimed limitation in detecting body composition. (LLM, conf=0.86)
- Partly supportedcites [93] matched to “Cut‐offs for calf circumference as a screening tool for low muscle mass: WASEDA'S Health Study” (2020) sourceExperimental — accuracy not yet measured
The Methods (Muscle mass measurements; page not available) use DXA, rather than BMI, to measure body fat percentage and lean tissue mass; the Results also define obesity by DXA-measured body fat percentage. This is consistent with a limitation of BMI for assessing body composition, but the paper does not discuss BMI's ability to detect fat distribution or explicitly characterize its limitations as important. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
37 more claims · 2 with their cited sources checked
Create a free account to see all 85 claims and to verify the 62 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 26
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More potent agents such as tirzepatide and high-dose semaglutide induce substantial weight loss (~ 15–24%) and reduce both fat and lean mass.”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenia definitions have evolved through European and Asian consensus updates that place greater emphasis on muscle strength and physical performance, while the ESPEN and EASO consensus and the Sarcopenic Obesity Global Leadership Initiative have attempted to standardize SO diagnosis and research priorities (2, 7–9).”
From Exercise-based interventions for sarcopenic obesity in middle-aged and older adults: an umbrella review of systematic reviews with pairwise meta-analyses and network meta-analyses (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Differential changes in the phenotypic criteria of SO have been generally gone undetected in terms of their impact on adverse health outcomes [1, 2, 3].”
From Sarcopenic Obesity Phenotype Index (SOP i ): A Population‐Based Study (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenesis of SO, while not fully elucidated, involves elevated adipose deposits leading to the expression of antimyogenic adipokines and pro‐inflammatory responses that accelerate muscle function and/or mass loss.”
From Sarcopenic Obesity Phenotype Index (SOP i ): A Population‐Based Study (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This promotes metabolic complications and inhibits the anabolic actions of insulin‐like growth factor IGF‐1, which have an effect on the musculoskeletal system [1, 21].”
From Sarcopenic Obesity Phenotype Index (SOP i ): A Population‐Based Study (2025) · cites this paper as [1]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Self-citation(2000) · PubMed · Cited by 13,173
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Self-citationSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Self-citationJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Self-citation
Research works printed but not linked: 1
- 10.1007/s10522-015-9626-484 · doi:10.1007/s10522-015-9626-484
Cited by
Items 901–1,000 of 1,001
Aplicação WEB para diagnóstico de sarcopenia
Coelho, L. B. (2024) · DSpace (Federal University of Santa Catarina)
La visión de la unidad de nutrición
Vidal‐Casariego, A. (2024) · Scientific Electronic library online (Sciences Carlos III Health Institute)
Sarcopènia en pacients amb obesitat severa intervinguts de cirurgia bariàtrica
Comas, M. (2023) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Mulligan, A. A. (2024) · UEA Digital Repository (University of East Anglia)
Tolvanen, L. (2023) · Open Archive (Karolinska Institutet)
(2024) · repository of the Library and Information Centre, Hungarian Academy of Sciences (REAL-J)
Nascimento, B. P. D. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Bradley, N. (2025) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.85439
Maruyama, M., Kajiwara, S., Oikawa, T., Sakai, R., & Sasaki, M. (2025) · Physical & Occupational Therapy In Geriatrics · doi:10.1080/02703181.2025.2559601
Effects of physical exercise on sarcopenia after bariatric surgery: a randomized controlled trial
Mendes, C. S. O. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Gartenschläger, J. A. (2025) · Gutenberg Open Science · doi:10.25358/openscience-13251
Imaging of Musculoskeletal Metabolic Diseases
Gazzotti, S., Sassi, R., Guglielmi, R., Gómez, M. P. A., & Bazzocchi, A. (2025) · Medical radiology · doi:10.1007/174_2025_591
Keep the muscles, lose the fat
Memelink, R. G. (2025) · VUBIR (Vrije Universiteit Brussel)
Koop, J. (2025) · MACAU: Open Access Repository of Kiel University
Sarcopenic obesity syndrome in elderly people
Ζηλίδου, Μ. Ε., & Ζηλίδου, Μ. Ε. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Réduction de la masse musculaire dans le syndrome de Cushing : étude SarCor
Clouaire, L., Cristante, J., Charriere, K., Artemova, S., Vilotitch, A., & Betry, C. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.103056
Καρανικόλα, Ν.-Ι. Κ., & Τικτοπούλου, Α.-Δ. Α. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Razširjenost sarkopenične debelosti med ledvičnimi bolniki na hemodializi
Brezočnik, L. (2023) · Repository of the University of Primorsk (University of Primorska)
Müller, M. J., & Bosy-Westphal, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00328-9
Kopylov, A. E., Агарков, Н. М., & Abramov, A. A. (2025) · Russian Annals of Ophthalmology · doi:10.17116/oftalma202514106122
Hu, Z., Dong, H., & Fei, Y. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03258-3
Cabañas-Alite, L., Merino-Torres, J. F., Gil-Andrés, D., & Soriano, J. M. (2025) · Nutrire · doi:10.1186/s41110-025-00400-z
NGUYEN, T. L., Tran, T. M., Tran, T. T. Q., Thanh, N. T., & Duong, T. P. (2025) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2025.12.010
Xu, Y., 石龙凯, Chen, L., Liu, J., & Ding, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-28449-w
Sarcopenia and obesity: Two sides of the same coin. Incretin technologies in addressing the problem
Demidova, T. Y., Толмачева, К. А., & Прилепа, С. А. (2025) · FOCUS Endocrinology · doi:10.62751/2713-0177-2025-6-4-06
LIJEČITI DEBLJINU I IZBJEĆI SARKOPENIJU – TERAPIJSKI IZAZOV U OSTEOARTRITISU
Pandzic, V. (2025) · Fizikalna i rehabilitacijska medicina · doi:10.21751/frm-39-4-20
Zaverukha, N. V., Grygorieva, N. V., Musiіenko, А. S., & Koshel, N. M. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.8.2025.1657
Risco de sarcopenia e seu valor prognóstico em idosos hospitalizados : um estudo prospectivo
do Nascimento, T. G. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
da SILVA, J. L. J. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Carvalho, E. S. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Factores predisponentes a sarcopenia en adultos mayores del área rural y urbana
Regalado, L. O. B., Mayorga, C. A. E., & Gómez, J. K. C. (2026) · Atención Primaria · doi:10.1016/j.aprim.2025.103380
Teng, Z., Dong, Y., & Duan, S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1670286
Miao, S., Zhang, X., & Yue, Q. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000004677
Reis-Silva, A., Cardoso, A. L. B. D., Coelho-Oliveira, A. C., Batouli-Santos, D., dos Santos, G. S. D., Mazini, J. S., Valério-Penha, A. G., ANDRADE-NASCIMENTO, A., Moura-Fernandes, M. C., Taïar, R., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16020316
SARCOPENIA AND INFLAMMATORY BOWEL DISEASE: DEVELOPMENTAL MECHANISMS AND PRACTICAL IMPLICATIONS
Romanukha, V., Гринів, О. І., Skrypnyk, L., Малинина, Н. С., & Cherniavska, I. (2025) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2025;13(4);910-918
Önür, N. H., Erdogan, T. O., & Bahat, G. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70322
Aydogan, O. O., Oksuzoglu, A. D., & Turanlı, B. (2026) · Metabolites · doi:10.3390/metabo16020095
Essomba, M.-J. N., Medoua, S. P., Nzana, V. B., Mahamat, M., Nono, A., Ndjong, E., Fouda, H., Ashuntantang, G. E., & Folefack, F. K. (2025) · Pan African Medical Journal · doi:10.11604/pamj.2025.52.116.48268
Shao, H., Wang, Y., Park, Y.-K., & Jung, H. W. (2026) · Nutrients · doi:10.3390/nu18030429
Sarcopenic Obesity in Aging Males: Imaging, Metrics, and Multimodal Intervention
Abeeri, H. A., Alshehri2, S. N., Alharbi, F. S., Alanazi, A. J. A., Almaqadi, Z. S. H., Aljohani, S. S., Alanazi, N. A., Alasiri, N. M., Alslobi, L. M. A., Alsmari, N. S. A., et al. (2024) · Saudi Journal of Medicine and Public Health · doi:10.64483/202412616
Corrêa, C. D., Portilho, I. C., & Luz, C. R. D. A. N. (2026) · Revista JRG de Estudos Acadêmicos · doi:10.55892/jrg.v9i20.2898
Antyukh, K. Y. (2026) · Emergency Cardiology and Cardiovascular Risks · doi:10.51922/2616-633x.2025.9.2.2548
Take a personalised approach to weight management for older adults with obesity
Brown, M. B. (2026) · Drugs & Therapy Perspectives · doi:10.1007/s40267-025-01213-w
Study of muscle strength using hand-held dynamometry in pediatric patients with obesity
Martín‐Rivada, Á., Hurtado, M. M., Camacho, E. S., & Fariña, Y. R. (2026) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2026.504103
Impact of Obesity on Vaginal Myomectomy Outcomes in the Management of Uterine Leiomyomas
Şahin, T., Şahin, E. A., & Sahin, H. (2026) · Gynecologic and Obstetric Investigation · doi:10.1159/000550970
Abudayeh, A. H., & Fishchenko, I. V. (2026) · Aging Clinical and Experimental Research · doi:10.1007/s40520-026-03329-z
Matsumoto, A., Yoshimura, Y., Wakabayashi, H., Nagano, F., Shimazu, S., Kido, Y., Hamada, T., Yoneda, K., Bise, T., & Kuzuhara, A. (2026) · European Geriatric Medicine · doi:10.1007/s41999-026-01419-9
Pozo, K., Frau, F., Succa, V., Donini, L. M., & Marini, E. (2026) · Nutrition · doi:10.1016/j.nut.2026.113156
Self-citationLee, D., Heo, D., Ryu, J., Kim, K. S., & Kim, M. (2026) · Research Square · doi:10.21203/rs.3.rs-8852127/v1
Sexual Dimorphism in the Development of Cardiometabolic Syndrome
Velasco, M., Albarado-Ibáñez, A., Larqué, C., Pánico, P., Torres-Jácome, J., & Hiriart, M. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_790
HOMA-IR Values in Overweight and Obesity Subjects With and Without Sarcopenia
Suhardi, F. L., Aman, A. M., Sudarso, A., Bakri, S., Rasyid, H., & Seweng, A. (2026) · F1000Research · doi:10.12688/f1000research.177884.1
Chou, W., Guidozzi, N., Giorgi, L., Salem, R., & Markar, S. R. (2026) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2026.111505
Association between DASH diet adherence and sarcopenia: the mediating role of adiposity indices
Liu, Y., Zhong, C., Li, S., Yang, L. I., Chen, W., & Yang, B. (2026) · European journal of medical research · doi:10.1186/s40001-026-04134-0
Yu, Q., Huang, S., Chen, Z., Zhu, J., Tan, Y., & Chen, X. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07083-9
Prevalence of and Factors Associated with Sarcopenic Obesity in People Living with HIV
Noppornpanth, P., Ratanasawan, W., Navanukroh, O., & Homsanit, M. (2026) · THE BANGKOK MEDICAL JOURNAL · doi:10.31524/bkkmedj.2026.11.007
A Comprehensive Review of the Association between Sarcopenia and COPD
Mădălina, T. A., Gherghiceanu, F., Mahler, B., & Andronic, O. (2026) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2026-0003
Assessment of Muscle Mass and Diagnosis of Sarcopenia in Peritoneal Dialysis Patients
Xu, L., Ng, J. K., Fung, W. W., Chan, G. C., Chow, K. M., & Szeto, C. (2026) · Kidney and Dialysis · doi:10.3390/kidneydial6010016
Zhu, Y., & Jia, J. (2026) · Research Square · doi:10.21203/rs.3.rs-8899879/v1
Russell, E., Nguyen, D., Page, S., Lee, Á., Silvers, M. A., Saxby, E., Holt, D. Q., Le, S. T. T., & Coombs, P. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103111
Conte, S. L., Bufano, A., Cevenini, G., Paolo, B., Castagna, M. G., & Alessandra, C. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106398
Самойлова, Ю. Г., Khoroshunova, E. A., Matveeva, M., & Kudlay, D. (2026) · Molekulyarnaya Meditsina (Molecular medicine) · doi:10.29296/24999490-2026-01-05
Targeting the gut microbiota as a treatment for obesity and cancer cachexia
Giannakogeorgou, A., van den Ende, T., Verhaar, B. J. H., de Clercq, N. C., van Laarhoven, H. W. M., & Nieuwdorp, M. (2025) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2026.2650180
Alğan, A., & Aydemir, H. A. (2026) · Research Square · doi:10.21203/rs.3.rs-8909415/v1
Vasilieva, L. V., Popov, S. Y., Гостева, Е. В., & Suslova, E. M. (2026) · Tuberculosis and lung diseases · doi:10.58838/2075-1230-2026-104-1-44-51
Effect of body fat on endurance performance in professional soldiers from Slovakia
Žiška, P., Markovič, R., & MELEK, P. (2026) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.25.05990-x
Kera, T., Kawai, H., Ejiri, M., Imamura, K., Sasai, H., Hirano, H., Fujiwara, Y., Ihara, K., & Obuchi, S. (2026) · International Journal of Obesity · doi:10.1038/s41366-026-02051-0
Jurdana, M., & Žiberna, L. (2026) · Biocell · doi:10.32604/biocell.2026.079591
Dong, L., Zhou, X., Li, L., Miao, H., Zou, T., Zhang, L., Han, Z., Kateer, A., Wu, R., & Aimaitijiang, D. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07118-1
Kartiko, D. C., Rejeki, P. S., Indarto, D., Subagio, I., Hartati, S. C. Y., Orhan, B. E., Nurwati, Y., & Pranoto, A. (2026) · Physical Education Theory and Methodology · doi:10.17309/tmfv.2026.2.16
Güngör, M., Bayat, A., & Eşme, M. (2026) · Osteoporosis International · doi:10.1007/s00198-026-07970-2
Skurk, T., Raab, H., & Riedl, M. (2026) · Springer eBooks · doi:10.1007/978-3-662-69828-0_9
Sarcopenic Obesity among the Elderly: Bridging Nutrition Gaps
Raja, D. (2026) · Chettinad Health City Medical Journal · doi:10.24321/2278.2044.202601
Antyukh, K. Y., Григоренко, Е. А., Vasilyeva, N. A., Semenova, N. V., Ивановна, Р. И., Курушко, Т. В., Sheptulina, A. F., Drapkina, O. M., & Mitkovskaya, N. P. (2026) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2026-2532
Ilchenko, L. Y., Ахмедов, В. А., Vinnitskaya, E. V., Иванович, Д. Е., Myazin, R. G., Nikitin, I. G., Tikhomirova, A. S., Khoroshilov, I., Myazin, R. G., Александровна, Э. О., et al. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-236-4-3-36
Slyvka, Y. I., Savka, Y. M., Krichfalushii, O. P., Feketa, V. P., & Moroz, O. O. (2026) · Україна Здоров’я нації · doi:10.32782/2077-6594/2026.1/09
Sarcopenic obesity in type 2 diabetes: An underrecognized clinical challenge
(2026) · Obesity Pillars · doi:10.1016/j.obpill.2026.100270
Kumar, N. B., Parker, N., Zhang, J., Pow-Sang, J., Park, J. Y., & Schell, M. J. (2026) · Cancers · doi:10.3390/cancers18081276
González-Gutiérrez, J. (2026) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/84124
Tripathi, P., KADAM, N. S., Kathrikolly, T., & GANLA, M. H. (2026) · Cureus · doi:10.7759/cureus.107273
Mendonça, F. M., Leite, A. R., Soares, P., Maia, M., Neves, J. S., Luís, C., Rodrigues, I., Carvalho, L., Alves, J., Fonseca, B., et al. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08672-8
Medical rehabilitation of patients with sarcopenia: a systematic review
Levitskaya, E. S., Batyushin, М. М., Orlova, S. V., Nalgieva, Z. M., Sarkisyan, S. S., Бондаренко, Н. Б., Blinov, A. Y., Osipyan, D. A., & Gul'chenko, V. (2026) · Russian Journal of Physiotherapy Balneology and Rehabilitation · doi:10.17816/rjpbr702980
Sarcopenia and physical performance among older adults with increased body mass index and falls
Hashim, N. N. A., Mat, S., Myint, P. K., Delibegović, M., Kioh, S. H., Kamaruzzaman, S. B., Hairi, N. N., Khoo, S., & Tan, M. P. (2026) · Scientific Reports · doi:10.1038/s41598-026-49574-0
Habboub, B., Oludowole, E., Speer, R., Masuch, J., Berger, U., Gosch, M., & Singler, K. (2026) · Health Science Reports · doi:10.1002/hsr2.72341
Ariya, M., Fahey, P. P., Homayounfar, R., & Atlantis, E. E. (2026) · Scientific Reports · doi:10.1038/s41598-026-49776-6
Barnabas Theodore, A., Rahul, S., Soundararajan, K., Aseer, A. L., Kanthanathan, S., & Mohanan, C. (2026) · Global Journal of Medical Pharmaceutical and Biomedical Update · doi:10.25259/gjmpbu_104_2025
Jang, K. (2026) · Australian Journal on Ageing · doi:10.1111/ajag.70174
Effets de l'âge et de l'activité physique sur la santé musculaire et mitochondriale chez l'humain
Marcangeli, V. (2026) · Archipel (Université du Québec à Montréal)
Silva, T., Silva, R., Lisboa, P. C., Bertasso, I. M., Kraemer‐Aguiar, L. G., & Mulder, A. D. R. P. (2026) · Research Square · doi:10.21203/rs.3.rs-9360148/v1
Alsheikh, S., Alabdullah, O. M., Alarify, G. A., Saqyan, M. I., Iqbal, K., & Altoijry, A. (2026) · Diagnostics · doi:10.3390/diagnostics16091378
Utami, F., Rusydiana, H. A., Dini, C. Y., Bertalina, & Wahyuni, E. S. (2026) · Amerta Nutrition · doi:10.20473/amnt.v10i1sp.2026.138-148
Tabakchi, O. E., Дамировна, М. Д., Bodryagina, E. S., Черемина, Н. А., Odintsova, A. K., & Abdulganieva, D. (2026) · Medical alphabet · doi:10.33667/2078-5631-2026-5-54-60
Pérez‐Santiago, L., Mora, I., Garcés‐Albir, M., Forner, E. M., Sabater-Orti, L., & Dorcaratto, D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103581
He, H., Hu, X., Luo, Y., Wu, Y., Gao, Y., Yu, J., Luo, K., & Qian, X. B. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02173-5
Self-citationSkeletal muscle mass and inflammation-based prognostic score as prognostic factors in oral cancer
Yamasaki, E., Yamasaki, S., Naito, M., Obayashi, F., Ito, N., & Yanamoto, S. (2026) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2026.04.038
Yu, Z. (2026) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70539
Metadata
- Authors
- Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., Frara, S., Frühbeck, G., Genton, L., Gepner, Y., Giustina, A., Gonzalez, M. C., Han, H.-S., Heymsfield, S. B., Higashiguchi, T., Laviano, A., Lenzi, A., Nyulasi, I., Parrinello, E., Poggiogalle, E., Prado, C. M., Salvador, J., Rolland, Y., Santini, F., Serlie, M. J., Shi, H., Sieber, C. C., Siervo, M., Vettor, R., Villareal, D. T., Volkert, D., Yu, J., Zamboni, M., & Barazzoni, R.
- Affiliations
- Sapienza University of Rome (IT)
- University of Padua (IT)
- University of Hohenheim (DE)
- Uppsala University (SE)
- University of North Carolina at Chapel Hill (US)
- Heidelberg University (DE)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Tel Aviv University (IL)
- Vita-Salute San Raffaele University (IT)
- Clinica Universidad de Navarra (ES)
- University Hospital of Geneva (CH)
- Seoul National University Bundang Hospital (KR)
- Pennington Biomedical Research Center (US)
- Fujita Health University (JP)
- Monash University (AU)
- University of Alberta (CA)
- Universidad de Navarra (ES)
- Inserm (FR)
- University of Pisa (IT)
- Amsterdam University Medical Centers (NL)
- Capital Medical University (CN)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Nottingham (GB)
- Baylor College of Medicine (US)
- Peking Union Medical College Hospital (CN)
- University of Verona (IT)
- University of Trieste (IT)
- ORCID
- Donini, Lorenzo M.
- Busetto, Luca
- Bischoff, Stephan C.
- Cederholm, Tommy
- Ballesteros-Pomar, Maria D.
- Batsis, John A.
- Boirie, Yves
- Cruz-Jentoft, Alfonso J.
- Dicker, Dror
- Frara, Stefano
- Frühbeck, Gema
- Genton, Laurence
- Gepner, Yftach
- Gonzalez, Maria Cristina
- Han, Ho-Seong
- Heymsfield, Steven B.
- Laviano, Alessandro
- Lenzi, Andrea
- Nyulasi, Ibolya
- Parrinello, Edda
- Poggiogalle, Eleonora
- Prado, Carla M.
- Salvador, Javier
- Rolland, Yves
- Santini, Ferruccio
- Serlie, Mireille J.
- Shi, Hanping
- Sieber, Cornel C.
- Siervo, Mario
- Vettor, Roberto
- Villareal, Dennis T.
- Volkert, Dorothee
- Yu, Jianchun
- Zamboni, Mauro
- Barazzoni, Rocco
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2022
- Volume
- 15
- Issue
- 3
- Pages
- 321-335
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC9210010
- OpenAlex
- W4225632118
- Cited by
- 1,019
- References
- 126
- Citations by year
- 2026: 287 · 2025: 281 · 2024: 246 · 2023: 156 · 2022: 49
- FWCI
- 113.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- HAL (submittedVersion, cc-by-nc)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056350)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- sarcopenic obesity, sarcopenia, obesity, diagnostic criteria, definitions, skeletal muscle mass, skeletal muscle function, body composition, excess adiposity, body mass index, waist circumference, disease staging
- MeSH terms
- Body Composition, Humans, Obesity, Prospective Studies, Body Mass Index, Muscle, Skeletal, Adiposity, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.